BioTissue manufactures the only Cryopreserved Amniotic Membrane (CAM) recognized by the FDA1 for reducing inflammation, minimizing corneal scarring and inhibiting angiogenesis. Our proprietary CryoTek® cryopreservation process maintains full biologic components including HC-HA/PTX3, a key matrix identified to be, in part, responsible for Amniotic Membrane's (AM) therapeutic benefits. 2 BioTissue is the proven industry leader for regenerative therapies in both Optometry and Ophthalmology providing CAM products that can be used in both in-office and surgical settings.
1. https://www.fda.gov/media/74873/download
2. Tighe, S., Mead, O. G., Lee, A., & Tseng, S. C. G. (2020). Basic science review of birth tissue uses in ophthalmology. Taiwan Journal of Ophthalmology, 10(1), 3–12.
